Dupuytren\'s disease was originally noted by Plater in 1614[@B1] and carries the eponym of Baron Guillaume Dupuytren, who first lectured on the disease in 1831.[@B2] Although Cline in 1777 and Cooper in 1822 had described the fascial contracture and its treatment by fasciotomy, they were not mentioned in Dupuytren\'s discussions.[@B1] Dupuytren\'s disease is a genetic disorder of abnormal collagen production and deposition in the hand that is commonly characterized by metacarpophalangeal (MP) and proximal interphalangeal (PIP) joint contractures in the ring and little fingers. Dupuytren\'s disease can affect all races, but people of northern European descent are most commonly affected,[@B3]^-^[@B5] with 3% to 6% of white adults acquiring the condition during their lifetime.[@B3],[@B6] Dupuytren\'s diathesis, which manifests as a more aggressive form of the disease, comprises a positive family history with 1 or more affected siblings or parents, male gender, age less than 50 years at onset, bilateral involvement, ectopic manifestations (particularly Garrod\'s pads), and Caucasian ethnicity.[@B7] Furthermore, evidence indicates that Dupuytren\'s disease is more likely to occur in those with certain underlying conditions such as diabetes,[@B8] thyroid disorders,[@B9] alcoholism,[@B10] and epilepsy.[@B3] Lower incidences of Dupuytren\'s occur in those afflicted by rheumatoid arthritis.[@B11]

Genetic analyses show that Dupuytren\'s disease is an autosomal dominant disorder with variable penetrance and gene expression.[@B12] Genetic predisposition, combined with diatheses, lifestyle choices, (eg, alcohol consumption), or trauma,[@B13],[@B14] can trigger micro ruptures of the collagen fibers of the palmar fascia, fibroblast proliferation, and differentiation of fibroblasts into myofibroblasts.[@B15],[@B16] The expanding fibroblast pool and excess collagen deposition cause nodule and cord formation in the palm or digits.

Dupuytren\'s disease is progressive, with onset typically occurring later in life and worsening over the course of several months to several years.[@B17] In early stages, skin pitting and dimpling are commonly observed as pretendinous bands connected to the dermis begin to contract.[@B18] Initially, nodules are painless and hand function is generally retained. However, as the disease progresses, cords begin to contract, causing finger flexion deformities and diminished hand function.[@B18] The contractile properties of myofibroblasts are thought to cause the cords to shorten,[@B15] resulting in the hallmark contractures that characterize Dupuytren\'s disease.

Few treatment options exist for those with Dupuytren\'s contracture. Surgery is currently the mainstay of treatment and is recommended for functionally impaired patients with MP joint contractures of more than 30°.^18-223^ Indications for the treatment of PIP joint contracture varies. Some authors recommend surgery for any degree of PIP contracture.[@B20],[@B22] Others feel that there should be approximately 15° (references [@B18], [@B24]) or 30° (reference [@B25]) of PIP contracture to warrant surgery. In contrast to these established guidelines, McGrouther asserts that it is better to "rely on functional difficulty and the rate of progression when deciding on surgery, rather than choosing a set amount of joint contracture."^26(p167)^

Open, limited (subtotal) fasciectomy is the most commonly used surgical procedure,[@B10],[@B27]^-^[@B30] but open or closed fasciotomies, including percutaneous needle fasciotomy (ie, needle aponeurotomy), are also performed.[@B31]^-^[@B35] Although surgery provides positive outcomes for most patients, extensive hand therapy is typically required after surgery. Not all patients with Dupuytren\'s contracture are candidates for surgery; advanced age, comorbidities, or both, often exclude patients from undergoing fasciectomy. In this circumstance, closed fasciotomy[@B26],[@B36] or needle aponeurtomy[@B35] is often recommended. To date, no effective pharmacotherapy has been approved for the treatment of Dupuytren\'s disease,[@B37] though an investigational procedure with *Clostridium histolyticum* collagenase (enzymatic fasciotomy) shows promise.[@B38]

Dupuytren\'s disease is not curable because it is a genetic disease and has a cellular basis. Surgeons can help improve hand impairment due to Dupuytren\'s disease by surgical techniques. These corrective surgical procedures improve hand function for most patients; however, intraoperative and postoperative complications are common. Recurrent disease is possible after all types of treatments, including fasciectomies.

Surgeons performing fasciectomies need to discuss potential complications and recurrence with their patients and set realistic expectations for efficacy and safety. Unfortunately, no concise source of estimated surgical complication rates exists. The purpose of this review is to provide a single resource of intraoperative and postoperative complications associated with fasciectomy for Dupuytren\'s disease.

METHODS {#S1}
=======

Identification of studies {#S1-1}
-------------------------

Analysis of surgical complications was limited to those associated with fasciectomy and aponeuroectomy. To identify published, original research that reported surgical complications associated with surgery for Dupuytren\'s disease, a MEDLINE search was conducted with the following search parameters: fasciectomy\[Title/Abstract\] OR aponeurectomy\[Title/Abstract\] OR surgery\[Title/Abstract\] OR operate\*\[Title/Abstract\] AND Dupuytren\*\[Title/Abstract\] NOT review\[Publication Type\]. Search limitations included human subjects, English language, and dates of October 31, 1988, to October 31, 2008.

Study selection {#S1-2}
---------------

Search results were manually evaluated for relevance. Studies that did not report complication rates associated with fasciectomy or aponeurectomy were not included in the analysis. Studies that reported complication rates associated with fasciotomy, aponeurotomy, amputation, or postsurgical application of the S-Quattro external fixation device were excluded. Case studies were also excluded.

Data analysis {#S1-3}
-------------

Overall complication rates, complication rates according to types of disease (primary or recurrent disease), and complication rates according to time (intraoperative vs postoperative) and type were collated. Studies that did not specifically state whether patients had primary disease or recurrent disease were assumed to have had primary disease.

Averages and ranges were calculated for each complication described. The manner in which complications were reported varied from study to study (ie, by ray/finger; by hand; by patient); conversion of all surgical complication rates to a common denominator was not possible. Average rates were calculated and ranges were reported for each surgical complication across studies; the sum of all numerators was divided by the sum of all denominators and multiplied by 100.

RESULTS {#S2}
=======

Study attributes {#S2-1}
----------------

A total of 143 articles were identified. One hundred two articles were excluded from the analysis (pathology, *n* = 16; treatment techniques, *n* = 17; postoperative care, *n* = 9; case studies, *n* = 13; long-term follow-up, *n* = 8; risk factors, *n* = 10; non-Dupuytren\'s disease, *n* = 12; surgery other than fasciectomy, *n* = 3; and other, *n* = 14). The remaining 41 articles met the inclusion criteria, reported complications associated with surgery for Dupuytren\'s disease, and were deemed appropriate for analysis: 27 evaluated primary (or otherwise not specified) disease, 2 evaluated recurrent disease, and 12 evaluated mixed populations (primary or recurrent disease) (Table [1](#T1){ref-type="table"}).[@B4],[@B10],[@B27],[@B30],[@B32],[@B39]^-^[@B74] Of the 41 studies, 28 studies reported overall surgical complication rates ranging from 3.6% to 39.1%.

Complications in patients with primary disease {#S2-2}
----------------------------------------------

Of the 27 studies that evaluated patients with primary disease,[@B10],[@B32],[@B47]^-^[@B63],[@B65]^-^[@B71],[@B74] 16 studies reported intraoperative complications. These complications included digital nerve injury (3.4%; range, 0.0%--7.7%) and digital artery injury (2.0%; range, 0.0%--2.6%) (Table [2](#T2){ref-type="table"}).[\*](#fn1){ref-type="other"}

All 27 primary-disease studies reported postoperative complications,[@B10],[@B32],[@B47]^-^[@B63],[@B65]^-^[@B71],[@B74] the most common being wound-healing complications (22.9%; range, 0.0%--86.0%), incisional scar pain (17.4%), dysesthesia/paresthesia (13.5%), hypoesthesia (10.1%; range, 6.0%--17.9%), flare reaction (9.9%; range, 2.1%--51.5%), reflex sympathetic dystrophy (5.8%; range, 0%--69.2%), infection (2.4%; range, 0--8.6%), and hematoma (2.1%; range, 0%--13%).

Complications in patients with recurrent disease {#S2-3}
------------------------------------------------

Only 2 studies examined patients with recurrent disease exclusively. One study did not report intraoperative complications; the other evaluated intraoperative complications and reported no digital artery injuries (Table [3](#T3){ref-type="table"}).[@B72],[@B73] Both studies reported postoperative complications: hyperesthesia (20.0%), local cold intolerance (20.0%), hypoesthesia (15.8%), and necrosis (11.1%). No cases of bleeding, infection, graft failure, or reflex sympathetic dystrophy were observed.

Complications in mixed populations (primary and recurrent diseases combined) {#S2-4}
----------------------------------------------------------------------------

Seven studies reported intraoperative complications in a mixed population (ie, primary and recurrent disease populations combined). The overall intraoperative complications in these studies were digital nerve injury (3.6%; range, 0.6%--7.8%), digital artery injury (3.3%; range, 0.8--9.7%), and tendon injury (0.02%) (Table [4](#T4){ref-type="table"}).[@B4],[@B27],[@B30],[@B40],[@B44],[@B46],[@B64]

Eleven mixed-population studies reported overall postoperative complications: the most common were stiffness (15.4%; range, 1.6%--51.5%), hypoesthesia (14.0%), scar hypertrophy (10.0%), and scar contracture (9.4%).[@B4],[@B27],[@B30],[@B39]^-^[@B43],[@B45],[@B46],[@B64]

Comparison of complications in patients with primary or recurrent disease {#S2-5}
-------------------------------------------------------------------------

Three studies reported surgical complication rates separately for patients with primary disease and recurrent disease (Table [5](#T5){ref-type="table"} and Fig [1](#F1){ref-type="fig"}).[@B27],[@B30],[@B64] Only one study reported overall complication rates, which were slightly higher in patients with primary disease (30.8%) than in those with recurrent disease (25.0%).[@B64] Digital artery injury and digital nerve injury were more commonly observed in patients with recurrent disease than those with primary disease. The incidence of digital artery injury and digital nerve injury was 1.7% (3/174) and 3.1% (7/224), respectively, in patients with primary disease and 25.7% (9/35) and 17.0% (10/59), respectively, in patients with recurrent disease, indicating a approximately 10-fold difference (˜2% vs ˜20%) (Fig [1](#F1){ref-type="fig"}).[@B27],[@B30],[@B64] However, the number of patients is too small for statistical significance.

DISCUSSION {#S3}
==========

Data from this analysis clearly demonstrate that complications associated with fasciectomy for the treatment of patients with Dupuytren\'s disease are varied and relatively common. Data from studies that evaluated patients with primary disease showed that wound-healing complications and pain were most common. Conversely, patients with recurrent disease were more likely to experience varied types of sensory abnormalities (eg, hyperesthesia, cold intolerance, hypoesthesia) and necrosis. Data from the few studies that directly compared patients with primary and recurrent diseases showed that digital nerve injuries and digital artery injuries were much more common in patients with recurrent disease (typically ˜20%) than those with primary disease (typically ˜2%), although larger numbers of patients are needed for a valid statistical comparison. Pain was less common in patients with recurrent disease, perhaps because those who previously underwent fasciectomy and developed a pain-related complication were unlikely to undergo surgery a second time.

Surgical complication rates in the present analysis were physician reported. A large patient survey study (*N* = 1177) conducted by the British Society for Surgery of the Hand provides insight into patient-reported complications after Dupuytren\'s surgery.[@B75] Patients with Dupuytren\'s disease were identified by hand surgeons throughout the United Kingdom and were invited to complete a questionnaire about surgical outcomes and complications. Patients\' self-reported complications were 35.8% for numbness and 19.8% for infection.[@B75] These values are much higher than the physician-reported complications rates provided in the current analysis.[@B75]

As with all surgeries, complication rates generally correlate with invasiveness of the procedure. Patients with severe disease often have greater tissue involvement and require more complex measures to correct the finger deformity. Consequently, patients with severe disease at the time of surgery tend to experience more complications postfasciectomy.[@B46],[@B75] A retrospective analysis of 253 patients with Dupuytren\'s disease who underwent fasciectomy showed that complication rates increased with the severity of disease, particularly when PIP joint contracture was more than 60°.[@B46] Dias and Braybrooke[@B75] made a similar observation, showing a clear relationship between the incidence of self-reported complications and the severity of the initial deformity, with patients who had severe disease at the time of surgery reporting more surgical complications. Loos et al[@B4] in a large study of almost 3000 patients noted a statistically significant correlation between worsening stage of the disease and postoperative complications.

Several limitations of the present analysis must be taken into consideration when interpreting the data. First, the manner in which complication rates were reported varied from study to study and included complications per ray or finger, per patient, and per hand. Conversion of complication rates to one common denominator was not possible, so the overall rates and ranges represent blended data. Given the large number of studies (*n* = 41) included in the analysis, overall interpretation should not be affected, though this limitation may explain why the ranges associated with some complications are relatively broad. Second, several factors, such as patient diathesis, baseline disease severity, the type of joint affected (ie, MP or PIP), and multiple digit involvement, that can impact the frequency of surgical complications were not analyzed separately. Complication rates in the present analysis are therefore based on a heterogeneous patient population and cannot be directly compared with a specific patient subset.

In the absence of an approved pharmacotherapy, surgery provides the best opportunity for long-term functional improvement for patients with Dupuytren\'s disease. Although complete restoration of hand function is unlikely, most patients will experience significant gain in function. However, several drawbacks to surgery exist. First, surgery does not cure Dupuytren\'s disease and recurrences rates are high, ranging from 26% to 80%.[@B37] Second, surgery in patients with recurrent disease is usually more challenging because scarring and anatomic distortion from prior procedure(s) increases the likelihood of neurovascular complications. Third, rehabilitation after open surgery may be prolonged. Finally, multiple, repetitive surgical procedures have their limitations and not all patients are good candidates for surgery.

CONCLUSIONS {#S4}
===========

This is the first report to extensively collect and analyze complications associated with surgery for Dupuytren\'s disease in clinical practice. Data from this study indicate that complications of surgery not only occur frequently but are also varied. Therefore, surgeons who perform fasciectomies for Dupuytren\'s disease should be mindful of the potential for intraoperative and postoperative complications and should counsel their patients accordingly. Furthermore, the severity of the disease and surgical history of the patient should be considered when anticipating complications. Patients undergoing fasciectomy for recurrent disease are more likely to experience either digital nerve injury or digital artery injury than patients with primary disease.

In conclusion, results of this study underscore the importance of treating Dupuytren\'s as an incurable genetic disease understanding that surgical excision, fasciectomy, has a high rate of major and minor complications. Surgeons must understand that while fasciectomy for Dupuytren\'s does offer a chance at long-term "straight" fingers, there is a high cost in terms of numbers of complications that are borne by the patient.
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###### 

Studies included in the analysis[\*](#TF1-001){ref-type="table-fn"}

  No.   Authors (year)                      Study design                                                                No. of patients            No. of hands         No. of joints                                                                                          Joint type         Follow-up period                                                                                 Surgical techniques                                                                                                                                                  Disease category
  ----- ----------------------------------- --------------------------------------------------------------------------- -------------------------- -------------------- ------------------------------------------------------------------------------------------------------ ------------------ ------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  1     Srivastava et al (1989)[@B39]       Retrospective                                                               10                         12                   NR                                                                                                     MP, PIP            1--10 y                                                                                          Fasciectomy, limited or radical; Z-plasty closure or open-palm technique; amputation for advanced disease                                                            Mixed: Primary, 70%; recurrent, 30%
  2     Sennwald (1990)[@B27]               Retrospective                                                               98                         103                  NR; 239 rays                                                                                           NR                 3--6 mo                                                                                          Fasciectomy, radical; rotation flap or Z-plasty                                                                                                                      Mixed: Primary, 74.8%; recurrent, 25.2%
  3     Moermans (1991)[@B40]               Prospective                                                                 175                        213                  503                                                                                                    MP, PIP            Mean, 2.6 ± 1.6 y; range, 0--7 y                                                                 Aponeurectomy, segmental                                                                                                                                             Mixed: Primary, 83.1%; recurrent, 16.9%
  4     Foucher et al (1992)[@B41]          Retrospective                                                               107                        NR                   NR; 140 digits                                                                                         MP, PIP            \>5 y                                                                                            Fasciectomy, limited; open-palm technique and/or digit                                                                                                               Mixed: Primary, 95%; recurrent, 5%
  5     Searle and Logan (1992)[@B42]       Retrospective                                                               32                         NR                   NR; 40 rays                                                                                            NR                 Mean, 38 mo; ≥24 mo                                                                              Dermofasciectomy                                                                                                                                                     Mixed: Primary, 53%; recurrent, 47%
  6     Beyermann et al (2004)[@B43]        Prospective                                                                 43                         43                   43                                                                                                     PIP                24 wk                                                                                            Fasciectomy (*n* = 32), with CLM release (*n* = 11)                                                                                                                  Mixed: Primary, 67.4%; recurrent, 32.6%
  7     Meathrel and Thoma (2004)[@B44]     Retrospective                                                               149                        NR                   NR; 261 digits                                                                                         NR                 NR                                                                                               Fasciectomy, palmar                                                                                                                                                  Mixed: Primary, 87.2%; recurrent, 12.8%
  8     Kobus et al (2007)[@B45]            Retrospective                                                               253                        287                  NR                                                                                                     MP, PIP            Mean, 3 y                                                                                        Fasciectomy, radical, with V-Y--plasty                                                                                                                               Mixed: Primary, 86.2%; recurrent, 13.8%
  9     Loos et al (2007)[@B4]              Retrospective                                                               2919                       4388                 NR                                                                                                     MP, PIP, DIP       NR; data span 50-y period                                                                        Fasciectomy, limited (94.8% of procedures) or total; amputation                                                                                                      Mixed: Primary, 88%; recurrent, 12%; data not complete
  10    Bulstrode et al (2005)[@B46]        Retrospective                                                               253                        NR                   NR                                                                                                     NR                 Mean, 3.6 y; range, 9 mo--11 y                                                                   Fasciectomy, modified Skoog\'s technique                                                                                                                             Mixed: Primary, 75.5% (191/253); recurrent, 24.5% (62/253)
  11    Ebskov et al (1997)[@B64]           Prospective                                                                 76                         NR                   NR; mean rays involved: primary, 2.1; recurrent, 1.8                                                   MP, PIP            3 wk                                                                                             Fasciectomy, radical, open-palm technique                                                                                                                            Mixed: Primary, 68.4%; recurrent, 31.6%
  12    Denkler (2005)[@B30]                Retrospective                                                               Hospital, 26; office, 40   NR                   Hospital, 73; office, 93; digits: hospital, 42; office, 60                                             MP, PIP            Hospital: mean, 10.6 ± 21.9 mo; median, 3 mo; office: 9.3 ± 9.5 mo; median, 4 mo                 Fasciectomy, hospital group (traditional anesthetics with tourniquet; 43 digits) vs office group (local anesthetics with epinephrine and no tourniquet; 60 digits)   Mixed: Hospital: primary, 88.5% (23/26); 11.5% (3/26); office: primary, 95.0% (38/40); 5.0% (2/40)
  13    Andrew and Kay (1991)[@B47]         Prospective                                                                 46                         50                   79                                                                                                     MP, PIP            12 mo                                                                                            Aponeurectomy, segmental                                                                                                                                             Primary, 100%
  14    Liu and Chen (1991)[@B48]           Retrospective                                                               27                         32                   NR; 58 digits                                                                                          NR                 Mean, 5.3 y; range, 1--16 y                                                                      Fasciectomy with longitudinal, lazy-s, zigzag, or transverse incision                                                                                                Primary, 100%
  15    Robins et al (1993)[@B49]           Prospective                                                                 50                         50                   NR                                                                                                     NR                 NR                                                                                               Fasciectomy, local; usually with zigzag incision                                                                                                                     Primary, 100%
  16    Cools and Verstreken (1994)[@B50]   Retrospective                                                               28                         33                   NR                                                                                                     MP, PIP            Mean, 2.5 y                                                                                      Fasciectomy, partial; open-palm technique                                                                                                                            Primary, 100%
  17    Citron and Nunez (2005)[@B51]       Prospective                                                                 79                         79                   NR                                                                                                     MP, PIP            ≥2 y                                                                                             Fasciectomy, modified Bruner incision (*n* = 47) vs longitudinal incision with Z-plasty closure (*n* = 33)                                                           Primary, 100%
  18    Van Giffen et al (2006)[@B52]       Retrospective                                                               38                         38                   63 (fifth ray only)                                                                                    MP, PIP            Mean, 54 mo; range, 27--75 mo                                                                    Fasciectomy, isolated limited or segmental; dermofasciectomy                                                                                                         Primary, 100%
  19    van Rijssen et al (2006)[@B32]      Prospective                                                                 113                        117                  127[†](#TF1-002){ref-type="table-fn"}                                                                  MP, PIP, DIP       6 wk                                                                                             Limited fasciectomy                                                                                                                                                  Primary, 100%
  20    Skoff (2004)[@B53]                  Prospective                                                                 30                         NR                   NR                                                                                                     MP, PIP            Synthesis: mean, 2.7 y; range, 2.0--3.0 y; open-palm technique: mean, 3.5 y; range, 3.1--4.0 y   Fasciectomy, "synthesis" technique (*n* = 20) vs open-palm technique (*n* = 10)                                                                                      Primary, 100%
  21    Ritchie et al (2004)[@B54]          Prospective                                                                 14                         19                   19                                                                                                     PIP                Mean, 36 mo; range, 35--39 mo                                                                    Fasciectomy (8 little fingers), with CLM release (11 little fingers)                                                                                                 Primary, 100%
  22    Misra et al (2007)[@B55]            Prospective                                                                 35                         NR                   52                                                                                                     MP, PIP            Mean, 1.5 y; range, 1--3 y                                                                       Fasciectomy with Z-plasty (19 joints) ± PIP joint release (33 joints)                                                                                                Primary, 100%
  23    Sorene et al (2007)[@B56]           Retrospective                                                               19                         22                   44                                                                                                     IP, MP, PIP, DIP   Mean, 30 mo; range, 12--118 mo                                                                   Fasciectomy, selective, through modified Bruner palmodigital incisions                                                                                               Primary, 100%
  24    Stahl and Calif (2008)[@B57]        Retrospective                                                               23                         26                   NR                                                                                                     MP, PIP, DIP       Mean, 2.5 y; range, 1.5--19 y                                                                    Fasciectomy, limited, through zigzag digitopalmar incision ± CLM release of PIP joint                                                                                NR
  25    Vigroux and Valentin (1992)[@B58]   Retrospective                                                               56                         76                   NR; 137 digits                                                                                         MP, PIP            Mean, 12 y, 7 mo; range, 10--22 y                                                                Fasciectomy, regional ± PIP capsulectomy                                                                                                                             NR
  26    Foucher et al (1995)[@B59]          Retrospective                                                               54                         NR                   NR; 67 digits                                                                                          MP, PIP            Mean, 6.6 y; ≥5 y                                                                                Fasciectomy, open-palm technique                                                                                                                                     NR
  27    De Maglio et al (1996)[@B60]        Retrospective                                                               124                        145                  NR                                                                                                     MP, PIP            Mean, 33 mo; range, 6--59 mo                                                                     Aponeurectomy, selective; Skoog\'s and/or Dieckman/Iselin routes of access                                                                                           NR
  28    Shaw et al (1996)[@B61]             Retrospective                                                               25                         26                   NR; 39 digits                                                                                          MP, PIP            9--19 y                                                                                          Fasciectomy, palmar; open-palm technique                                                                                                                             NR
  29    Weinzweig et al (1996)[@B62]        Retrospective                                                               28                         42                   42                                                                                                     PIP                Mean, F, 10.1 mo; F + C, 6.4 mo                                                                  Fasciectomy (18 patients, 27 joints); F + C; 10 patients, 15 joints)                                                                                                 NR
  30    Citron and Messina (1998)[@B63]     Retrospective                                                               13                         NR                   NR; 18 digits                                                                                          PIP                Mean, 18 mo; range, 2--30 mo                                                                     Preoperative traction + fasciectomy ± fasciotomy                                                                                                                     NR
  31    Gonzalez et al (1998)[@B74]         Retrospective                                                               16                         19                   40                                                                                                     IP, MP, PIP        Mean, 25 mo; range, 6--168 mo                                                                    Fasciectomy, selective, with Z-plasty; fasciectomy, segmental, with multiple curvilinear incisions or Z-plasty                                                       NR
  32    Clibbon and Logan (2001)[@B65]      Retrospective                                                               56                         67                   67                                                                                                     MP                 Mean, 30 mo; range, 12--86 mo                                                                    Aponeurectomy, segmental (palmar)                                                                                                                                    NR
  33    Evans et al (2002)[@B66]            Retrospective (1983--1993; TA only); prospective (1993--1999, TA and NTA)   268                        NR                   NR; mean number of digits undergoing surgery: 1.96 (TA); 1.6 (NTA)[‡](#TF1-002){ref-type="table-fn"}   MP, PIP            NR                                                                                               Fasciectomy, with TA (*n* = 103) or NTA (*n* = 165)                                                                                                                  NR
  34    Barr et al (2003)[@B67]             Retrospective                                                               5                          5                    14                                                                                                     MP, PIP            Mean, 14 mo; range, 3--34 mo                                                                     Fasciectomy, with Z-plasty + intramuscular tenotomy of flexor digitorum superficialis in distal forearm                                                              NR
  35    Abe et al (2004)[@B68]              Retrospective                                                               57                         73                   146                                                                                                    IP, MP, PIP        Mean, 4 y; range, 2--17 y                                                                        Fasciectomy, subtotal                                                                                                                                                NR
  36    Ali et al (2006)[@B69]              Retrospective                                                               32                         35                   NR                                                                                                     NR                 Mean, 6 mo; range, 2--13                                                                         Fasciectomy, selective regional; ulnar-based skin flap                                                                                                               NR
  37    Coert et al (2006)[@B10]            Retrospective                                                               261 (558 operations)       556                                                                                                                         MP, PIP, DIP       Mean, 7.3±0.44 y; range, 0.3--48 y                                                               Fasciectomy, partial                                                                                                                                                 NR; average number of operations was 2.54 per patient over 8-y study period
  38    Reuben et al (2006)[@B70]           Prospective                                                                 300                        NR                   NR                                                                                                     NR                 1, 3, 12 mo postsurgery                                                                          Fasciectomy, with general anesthesia, axillary block, or intravenous regional anesthesia with lidocaine ± clonidine                                                  NR
  39    Anwar et al (2007)[@B71]            Retrospective                                                               657; 109 women, 548 men    119 women, 589 men   123 women, 760 men                                                                                     MP, PIP, DIP       NR                                                                                               Fasciectomy, fasciectomy + local flap, dermofasciectomy                                                                                                              NR
  40    Ekerot (1995)[@B72]                 Retrospective                                                               15                         16                   NR; 17 flaps                                                                                           MP, PIP            ≤2 y                                                                                             Fasciectomy, radical, with distally based dorsal hand flap; PIP joint capsulectomy in 4 fingers                                                                      Recurrent, 100%
  41    Roush and Stern (2000)[@B73]        Retrospective                                                               19                         NR                   NR; 28 digits                                                                                          MP, PIP, DIP       Median, 4 y; range, 1--15 y                                                                      Fasciectomy, limited, and IP arthrodesis; dermofasciectomy; fasciectomy and local flaps                                                                              Recurrent, 100%

\*NR indicates not reported; TA, tension applied; NTA, no tension applied; MP, metacarpophalangeal; PIP, proximal interphalangeal; DIP; distal interphalangeal; IP, interphalangeal; fasciectomy + capsulotomy; capsuloligamentous.

†An additional 150 joints were treated with percutaneous needle fasciotomy but were excluded from this analysis.

‡An additional 150 finger joints were treated with percutaneous needle fasciotomy but were excluded from this study since this study is discussingcomplications of surgical fasciectomy (excsion) for Dupuytren\'s.

###### 

Reported complications[\*](#TF2-001){ref-type="table-fn"} of surgery for primary Dupuytren\'s disease

  Complication                                                                                                               No. of studies reporting complications   Average, % (*n*/*N*)   Range, %
  -------------------------------------------------------------------------------------------------------------------------- ---------------------------------------- ---------------------- -----------
  Intraoperative                                                                                                                                                                             
     Digital artery injury[@B10],[@B52],[@B54],[@B71]                                                                        4                                        2.0 (20/989)           0--2.6
     Digital nerve injury[†](#TF2-002){ref-type="table-fn"}                                                                  15                                       3.4 (51/1510)          0--7.7
  Postoperative                                                                                                                                                                              
     Amputation (classified as postoperative complication)[@B10]                                                             1                                        1.5 (4/261)            ...
     Carpal tunnel syndrome[@B56],[@B62]                                                                                     2                                        6.4 (3/47)             3.6--10.5
     Clinodactyly[@B50]                                                                                                      1                                        3.0 (1/33)             ...
     Complex regional pain syndrome (see "reflex sympathetic dystrophy")                                                                                              ...                    ...
  Contracture[@B48],[@B63]                                                                                                   2                                        6.7 (3/45)             6.2--7.7
  Dysesthesia or paresthesia[@B32],[@B59]                                                                                    2                                        13.5 (15/111)          3.7--22.8
  Edema[@B62]                                                                                                                1                                        7.1 (2/28)             ...
  Flare reaction[@B66],[@B71]                                                                                                2                                        9.9 (92/925)           2.1--51.5
  Flexion, loss of[@B47],[@B49]                                                                                              2                                        4.2 (4/96)             4.0--4.3
  Hematoma[@B32],[@B48]^-^[@B50],[@B55],[@B57],[@B59],[@B68],[@B70]                                                          9                                        2.1 (14/657)           0--13.0
  Hyperesthesia[@B50]                                                                                                        1                                        3.0 (1/33)             ...
  Hypoesthesia[@B50],[@B52],[@B62]                                                                                           3                                        10.1 (10/99)           6.0--17.9
  Incisional scar pain[@B57]                                                                                                 1                                        17.4 (4/23)            ...
  Infection[‡](#TF2-003){ref-type="table-fn"}                                                                                19                                       2.4 (44/1860)          0--8.6
  Necrosis (skin, flap, or graft)[@B10],[@B49],[@B50],[@B52],[@B53],[@B59],[@B60],[@B62],[@B68],[@B69]                       10                                       4.3 (31/713)           0--10
  Pain (not otherwise specified)[@B50],[@B59]                                                                                2                                        13.8 (12/87)           3--20.3
  Reflex sympathetic dystrophy (complex regional pain syndrome)[@B10],[@B49]^-^[@B53],[@B57]^-^[@B63],[@B65],[@B70],[@B71]   16                                       5.8 (106/1828)         0--69.2
  Stiffness[@B62]                                                                                                            1                                        3.6 (1/28)             ...
  Swan neck deformity[@B54]                                                                                                  1                                        7.1 (1/14)             ...
  Tenosynovitis[@B50]                                                                                                        1                                        3.0 (1/33)             ...
  "Trigger finger"[@B56]                                                                                                     1                                        5.3 (1/19)             ...
  Wound-healing complication[@B32],[@B47],[@B49],[@B58],[@B60],[@B62],[@B66],[@B67][∥](#TF2-005){ref-type="table-fn"}        8                                        22.9 (145/634)         0--86.0.

\*Studies that reported no cases of a particular complication were included in calculations.

†*References [@B10], [@B32], [@B47], [@B49], [@B51], [@B53]-[@B55], [@B57], [@B61], [@B62], [@B65], [@B68], [@B71]*.

‡*References [@B10], [@B32], [@B48]-[@B50], [@B52]-[@B56], [@B60], [@B62], [@B65], [@B67]-[@B71], [@B74]*.

§Includes cases of algodystrophy.

∥One study reported no wound dehiscence.

###### 

Reported complications[\*](#TF3-001){ref-type="table-fn"} of surgery for recurrent Dupuytren\'s disease

  Complication                                                          No. of studies reporting complication   Average, % (*n*/*N*)
  --------------------------------------------------------------------- --------------------------------------- ----------------------
  Intraoperative                                                                                                
  Digital artery injury[@B73] (anesthetic)                              1                                       0 (0/19)
  Postoperative                                                                                                 
  Bleeding[@B72]                                                        1                                       0 (0/17)
  Graft failure[@B73]                                                   1                                       0 (0/19)
  Hyperesthesia[@B72]                                                   1                                       20.0 (3/15)
  Hypoesthesia[@B73]; poor to fair numbness noted postoperatively       1                                       15.8 (3/19)
  Infection[@B72],[@B73]                                                2                                       0 (0/36)
  Necrosis (skin, flap, or graft)[@B72],[@B73]                          2                                       11.1 (4/36)
  Reflex sympathetic dystrophy (complex regional pain syndrome)[@B73]   1                                       0 (0/19)
  Local cold intolerance[@B72]                                          1                                       20.0 (3/15)

\*Studies that reported no cases of a particular complication were included in calculations.

###### 

Reported complications[\*](#TF4-001){ref-type="table-fn"} of surgery for primary and recurrent Dupuytren\'s diseases (mixed populations)

  Complication                                                                                      No. of studies reporting complication   Average, % (*n*/*N*)   Range, %
  ------------------------------------------------------------------------------------------------- --------------------------------------- ---------------------- -----------
  Intraoperative                                                                                                                                                   
     Digital artery injury[@B27],[@B30],[@B46]                                                      3                                       3.3 (14/422)           0.8--9.7
     Digital nerve injury[@B4],[@B27],[@B30],[@B40],[@B44],[@B46],[@B64]                            7                                       3.6 (135/3779)         0.6--7.8
     Tendon injury[@B4]                                                                             1                                       0.2 (5/2919)           ...
  Postoperative                                                                                                                                                    
  Bleeding[@B4]                                                                                     1                                       1.2 (35/2919)          ...
  Complex regional pain syndrome (see "reflex sympathetic dystrophy")                                                                                              
  Carpal tunnel syndrome[@B46]                                                                      1                                       0.8 (2/253)            ...
  Severe dysesthesia leading to amputation[@B27]                                                    1                                       1.0 (1/103)            ...
  Flexion, loss of[@B30]                                                                            1                                       1.5 (1/66)             ...
  Graft failure leading to amputation[@B42]                                                         1                                       3.1 (1/32)             ...
  Hematoma[@B27],[@B30],[@B40],[@B46],[@B64]                                                        5                                       1.8 (13/711)           1.3--2.9
  Hypoesthesia[@B43]                                                                                1                                       14.0 (6/43)            ...
  Infection[@B4],[@B27],[@B30],[@B46],[@B64]                                                        5                                       3.9 (134/3424)         0.9--10.5
  Necrosis (skin, flap, or graft)[@B4],[@B30],[@B40],[@B45],[@B46],[@B64]                           6                                       2.5 (93/3780)          0--9.2
  Transient paralysis[@B27][†](#TF4-002){ref-type="table-fn"}                                       1                                       0.9 (1/103)            ...
  Reflex sympathetic dystrophy (complex regional pain syndrome)[@B27],[@B40],[@B41],[@B46],[@B64]   5                                       4.5 (34/752)           0--18.4
  Scar contracture from graft[@B42]                                                                 1                                       9.4 (3/32)             ...
  Scar hypertrophy[@B39]                                                                            1                                       10.0 (1/10)            ...
  Stiffness[@B27],[@B45]                                                                            2                                       15.4 (55/356)          1.6--51.5
  Vascular damage[@B45]                                                                             1                                       0.8 (2/253)            ...
  Wound dehiscence[@B30]                                                                            1                                       4.5 (3/66)             ...
  Wound-healing complications such as skin edge necrosis or slough[@B46]                            1                                       1.2 (3/253)            ...

\*Studies that reported no cases of a particular complication were included in calculations.

†Transient paralysis assumed to be caused by a tourniquet.

###### 

Intrastudy comparison of surgical complications[\*](#TF5-001){ref-type="table-fn"} in patients with primary or recurrent Dupuytren\'s disease

  Complication                                              Primary, % (*n*/*N*)   Recurrent, % (*n*/*N*)
  --------------------------------------------------------- ---------------------- ------------------------
  Overall                                                   30.8 (16/52)[@B64]     25.0 (6/24)[@B64]
  Digital nerve injury                                      1.3 (1/77)[@B27]       26.9 (7/26)[@B27]
                                                            1.5 (1/95)[@B30]       22.2 (2/9)[@B30]
                                                            9.6 (5/52)[@B64]       4.2 (1/24)[@B64]
  Digital artery injury                                     2.6 (2/77)[@B27]       30.8 (8/26)[@B27]
                                                            1.0 (1/97)[@B30]       11.1 (1/9)[@B30]
  Hematoma                                                  1.9 (1/52)[@B64]       0 (0/24)[@B64]
                                                            0 (0/77)[@B27]         7.7 (2/26)[@B27]
  Skin necrosis (marginal)                                  7.7 (4/52)[@B64]       12.5 (3/24)[@B64]
  Infection (superficial)                                   12.0 (6/52)[@B64]      4.2 (1/24)[@B64]
  Infection (deep joint infection that led to amputation)   0 (0/52)[@B64]         4.2 (1/24)[@B64]

\*Studies that reported no cases of a particular complication were included in calculations.
